Search Press releases Keywords From To 30 Oct 2008 New Cimzia® study shows rapid reduction of symptoms and progression of rheumatoid arthritis Read More 29 Oct 2008 UCB's Vimpat® approved by U.S. FDA as adjunctive therapy for partial onset seizures in adults Read More 25 Sep 2008 UCB withdraws EU marketing authorisation application for lacosamide in diabetic neuropathic pain Read More 16 Sep 2008 Changes in UCB's Executive Committee Read More 15 Sep 2008 Keppra XR(TM) approved in the U.S. Read More 12 Sep 2008 Information Regarding UCB as an Issuer by Virtue of Articles 15 and 18 of the Law of 2 May 2007 on the Disclosure of Major Holdings, as of 1 September 2008 Read More Pagination First page Previous page Previous … Page 170 Page 171 Page 172 Page 173 Current page 174 Page 175 Page 176 Page 177 Page 178 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
